Delayed Tolerance Through Mixed Chimerism
Latest Information Update: 10 Jun 2024
At a glance
- Drugs Siplizumab (Primary) ; Cyclophosphamide; Fludarabine; Rituximab
- Indications Bone marrow transplant rejection; Renal transplant rejection
- Focus Therapeutic Use
- 02 Apr 2024 Planned End Date changed from 1 Dec 2029 to 1 Dec 2030.
- 02 Apr 2024 Planned primary completion date changed from 1 Dec 2026 to 1 Dec 2028.
- 04 Oct 2023 Status changed from not yet recruiting to recruiting.